Gc-MAF Knowledge Base

Macrophages are cells within the tissues that originate from specific white blood cells called monocytes. Monocytes and macrophages are phagocytes, acting in both nonspecific defence (or innate immunity) as well as specific defense (or cell-mediated immunity) of vertebrate animals. Their role is to phagocytize (engulf and then digest) cellular debris and pathogens either as stationary or mobile cells, and to stimulate lymphocytes and other immune cells to respond to the pathogen.

In some case a disease blocks the macrophages from becoming activated. The immune system becomes unbalanced and pathogens can multply freely. Gc-MAF (vitamin D₃-binding protein (Gc protein)-derived macrophage activating factor) reactivates macrophages.

Research dating back until 1993 indicates Gc-MAF activates the immune system, thereby curing Cancer, Osteoporosis and HIV. Please feel free to browese the research section to read for yourself.

We patients have studied these reports and what strikes us is that most people in those studies had surgery before Gc-MAF treatment, used a special type of radiation therapy in conjuction etc. Although the results from Yamamoto's work seem incredible, amongst the group of patients here, none have been on Gc-MAF long enough for such remarkable results.

There is a little confusion about the number of injections required for HIV. One paper states 18 another only 6. In our opionion the latter is far to optimistic, especially if co-infections are present or if the viral load is higher. (Eg. EBV requires 35 injections). If you read the paper correctly, it states that as of 6 injections SOME of the participants are starting to show better cell counts, but only after 18 all participants meet the required standards.

It is also remarkable that none of the HIV patients in the study were anemic, while very often people with chronic infections have chronic anemia too. What role possible anemia could play in the less favorable outcome of Gc-MAF treatment is unkown at this stage, we can however imagine it would be more beneficial to have normal iron (related) levels.

We provide you with this knowledge base to increase awareness regarding the potential of Gc-MAF as a treatment in many diseases where the failing immunesystem plays an important role and to provide all patients following Gc-MAF treatment with a "patient platform" to exhange experiences and discuss their treatment.

Please click here to request a patient account, enter a valid email address and provide us with your preferred username.

Please click here for inquiries how to obtain Gc-MAF via trials etc.

Dr. Marco Ruggiero Announces the

publication of his work (july 24th

2010) regarding HIV and Gc-MAF.

A study that also focuses on

genetics, why most people do

respond to Gc-MAF treatment

and some people do not. His

current research focuses on making

the 'non-responders' respond.